
Intellipharmaceutics International Inc
TSX:IPCI

Fundamental Analysis



Revenue & Expenses Breakdown
Intellipharmaceutics International Inc
Balance Sheet Decomposition
Intellipharmaceutics International Inc
Current Assets | 861.9k |
Cash & Short-Term Investments | 400.1k |
Receivables | 268.2k |
Other Current Assets | 193.6k |
Non-Current Assets | 703.9k |
PP&E | 703.9k |
Free Cash Flow Analysis
Intellipharmaceutics International Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Intellipharmaceutics International Inc
Revenue
|
904.9k
USD
|
Cost of Revenue
|
-1.7m
USD
|
Gross Profit
|
-805k
USD
|
Operating Expenses
|
-1.8m
USD
|
Operating Income
|
-2.6m
USD
|
Other Expenses
|
-594.1k
USD
|
Net Income
|
-3.2m
USD
|
IPCI Profitability Score
Profitability Due Diligence
Intellipharmaceutics International Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Score
Intellipharmaceutics International Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
IPCI Solvency Score
Solvency Due Diligence
Intellipharmaceutics International Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Score
Intellipharmaceutics International Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IPCI Price Targets Summary
Intellipharmaceutics International Inc
Dividends
Current shareholder yield for IPCI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?